A detailed history of Fielder Capital Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fielder Capital Group LLC holds 379 shares of LLY stock, worth $336,154. This represents 0.13% of its overall portfolio holdings.

Number of Shares
379
Previous 378 0.26%
Holding current value
$336,154
Previous $294 Million 16.69%
% of portfolio
0.13%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $724 - $909
1 Added 0.26%
379 $343 Million
Q1 2024

Apr 25, 2024

SELL
$592.2 - $792.28 $7,106 - $9,507
-12 Reduced 3.08%
378 $294 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $204,824 - $241,460
390 New
390 $227 Million

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fielder Capital Group LLC Portfolio

Follow Fielder Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fielder Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fielder Capital Group LLC with notifications on news.